Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * Disallow: |
Title | Ascendia Pharmaceuticals | Products and Novel |
Description | First in Man Oraland Parenteral Dosage You are using an outdated browser. Please upgrade your browser to improve your experience. CALL 732-640-0058 or fill out form below and an Ascendia Pharma |
Keywords | N/A |
WebSite | ascendiapharma.com |
Host IP | 166.62.108.22 |
Location | United States |
Site | Rank |
US$28,982,766
Last updated: 2022-06-18 17:21:47
ascendiapharma.com has Semrush global rank of 365,193. ascendiapharma.com has an estimated worth of US$ 28,982,766, based on its estimated Ads revenue. ascendiapharma.com receives approximately 3,344,166 unique visitors each day. Its web server is located in United States, with IP address 166.62.108.22. According to SiteAdvisor, ascendiapharma.com is safe to visit. |
Purchase/Sale Value | US$28,982,766 |
Daily Ads Revenue | US$26,754 |
Monthly Ads Revenue | US$802,600 |
Yearly Ads Revenue | US$9,631,196 |
Daily Unique Visitors | 222,945 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
ascendiapharma.com. | A | 599 | IP: 166.62.108.22 |
ascendiapharma.com. | NS | 3600 | NS Record: ns13.domaincontrol.com. |
ascendiapharma.com. | NS | 3600 | NS Record: ns14.domaincontrol.com. |
ascendiapharma.com. | MX | 3600 | MX Record: 0 ascendiapharma-com.mail.protection.outlook.com. |
ascendiapharma.com. | TXT | 3600 | TXT Record: v=spf1 include:secureserver.net -all |
ascendiapharma.com. | TXT | 3600 | TXT Record: NETORG8854822.onmicrosoft.com |
You are using an outdated browser. Please upgrade your browser to improve your experience. CALL 732-640-0058 or fill out form below and an Ascendia Pharmaceutical expert will reach out to you within 24 hours. SEARCH --> (732) 640-0058 NEWSROOM CAREERS WHY ASCENDIA? WHAT WE DO LEADERSHIP TECHNOLOGIES EMULSOL AMORSOL NANOSOL CONTROLLED RELEASE SERVICES DEVELOPMENT TIMING IND-ENABLING FORMULATIONS FOR TOXICOLOGY AND PK STUDIES RAPID DEVELOPMENT THROUGH PHASE I CTM DISCOVERY FORMULATION SUPPORT SPECIAL DEVELOPMENT PROGRAMS FORMULATIONS FOR POORLY SOLUBLE AND LOW BIOAVAILABILITY DRUGS PARENTERAL FORMULATION DEVELOPMENT NANO FORMULATIONS BIOLOGICAL FORMULATION DEVELOPMENT 505(b)(2) PRODUCT DEVELOPMENT COMPLEX GENERICS ANIMAL HEALTH FORMULATIONS HIGH POTENCY MOLECULES MANUFACTURING ORAL DOSAGE FORMS PARENTERAL DOSAGE FORMS STABILITY STUDIES ANALYTICAL SCIENCES DOSAGE FORM DEVELOPMENT OUR FACILITY & EQUIPMENT PARTNER WITH ASCENDIA CONTACT (732) 640-0058 NEWSROOM CAREERS WHY ASCENDIA? |
HTTP/1.1 301 Moved Permanently Age: 0 Content-Security-Policy: upgrade-insecure-requests Content-Type: text/html; charset=iso-8859-1 Date: Fri, 22 Oct 2021 15:48:50 GMT Location: https://ascendiapharma.com/ Vary: User-Agent, Accept-Encoding X-Backend: local X-Cache: uncached X-Cache-Hit: MISS X-Cacheable: NO:HTTPS Redirect HTTP/2 200 server: openresty date: Fri, 22 Oct 2021 15:48:50 GMT content-type: text/html; charset=UTF-8 content-length: 52394 accept-ranges: bytes age: 32374 content-security-policy: upgrade-insecure-requests strict-transport-security: max-age=300 vary: Accept-Encoding, User-Agent x-backend: local x-cache: cached x-cache-hit: HIT x-cacheable: YES:Forced x-content-type-options: nosniff x-xss-protection: 1; mode=block strict-transport-security: max-age=31536000; includeSubDomains |
Domain Name: ASCENDIAPHARMA.COM Registry Domain ID: 1738133829_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-01-22T14:00:20Z Creation Date: 2012-08-10T04:00:55Z Registry Expiry Date: 2022-08-10T04:00:55Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS13.DOMAINCONTROL.COM Name Server: NS14.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T06:09:59Z <<< |